Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Geoff P Garnett"'
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e75552 (2013)
Recent trials have indicated that women with prior exposure to Human papillomavirus (HPV) subtypes 16/18 receive protection against reinfection from the HPV vaccines. However, many of the original models investigating the cost effectiveness of differ
Externí odkaz:
https://doaj.org/article/5a553d0c93e447ceb4486b0ab548d483
Autor:
Pablo E Campos, Anne L Buffardi, César P Cárcamo, Patricia J García, Clara Buendia, Marina Chiappe, Geoff P Garnett, Ana Maria Xet-Mull, King K Holmes
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81041 (2013)
As part of a community-randomized trial of a multicomponent intervention to prevent sexually transmitted infections, we created Mobile Teams (MTs) in ten intervention cities across Peru to improve outreach to female sex workers (FSW) for strengthened
Externí odkaz:
https://doaj.org/article/4affdc8c7997462db68d9190ddc6ad82
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47750 (2012)
Sexually Transmitted diseases (STD) syndrome management has been one cornerstone of STD treatment. Persons with STD symptoms in many countries, especially those with limited resources, often initially seek care in pharmacies. The objective of the stu
Externí odkaz:
https://doaj.org/article/72951ac96b26436785ceeffd30d9419c
Autor:
Gabriela B Gomez, Annick Borquez, Carlos F Caceres, Eddy R Segura, Robert M Grant, Geoff P Garnett, Timothy B Hallett
Publikováno v:
PLoS Medicine, Vol 9, Iss 10, p e1001323 (2012)
HIV pre-exposure prophylaxis (PrEP), the use of antiretroviral drugs by uninfected individuals to prevent HIV infection, has demonstrated effectiveness in preventing acquisition in a high-risk population of men who have sex with men (MSM). Consequent
Externí odkaz:
https://doaj.org/article/0c515a14630f4afdad0751753b143da1
Autor:
Laurent Coudeville, Geoff P Garnett
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51244 (2012)
BACKGROUND: With approximately 2.5 billion people at risk, dengue is a major international public health concern. Dengue vaccines currently in development should help reduce the burden associated with this disease but the most efficient way of using
Externí odkaz:
https://doaj.org/article/9ef0f6b751314a6eb08222345db465e0
Publikováno v:
PLoS ONE, Vol 4, Iss 5, p e5720 (2009)
The BED Capture Enzyme Immunoassay, believed to distinguish recent HIV infections, is being used to estimate HIV incidence, although an important property of the test--how specificity changes with time since infection--has not been not measured.We co
Externí odkaz:
https://doaj.org/article/083452af781445caad56b2eb5e64130e
Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa.
Autor:
Timothy B Hallett, Kanwarjit Singh, Jennifer A Smith, Richard G White, Laith J Abu-Raddad, Geoff P Garnett
Publikováno v:
PLoS ONE, Vol 3, Iss 5, p e2212 (2008)
Three randomised controlled trials have clearly shown that circumcision of adult men reduces the chance that they acquire HIV infection. However, the potential impact of circumcision programmes--either alone or in combination with other established a
Externí odkaz:
https://doaj.org/article/f19a3e3165714d0a94af6e5c8d3af37a
Publikováno v:
PLoS Medicine, Vol 5, Iss 3, p e53 (2008)
BackgroundThe roll-out of antiretroviral treatment (ART) in developing countries concentrates on finding patients currently in need, but over time many HIV-infected individuals will be identified who will require treatment in the future. We investiga
Externí odkaz:
https://doaj.org/article/5ab9edce2b854fa5ba7001164f3345c6
Autor:
Ben A Lopman, Ruanne V Barnabas, J Ties Boerma, Godwin Chawira, Kezia Gaitskell, Tara Harrop, Peter Mason, Christl A Donnelly, Geoff P Garnett, Constance Nyamukapa, Simon Gregson
Publikováno v:
PLoS Medicine, Vol 3, Iss 8, p e312 (2006)
Vital registration and cause of death reporting is incomplete in the countries in which the HIV epidemic is most severe. A reliable tool that is independent of HIV status is needed for measuring the frequency of AIDS deaths and ultimately the impact
Externí odkaz:
https://doaj.org/article/3364821b5b744bc4bce079d5c6a9e2f1
Autor:
Ruanne V Barnabas, Päivi Laukkanen, Pentti Koskela, Osmo Kontula, Matti Lehtinen, Geoff P Garnett
Publikováno v:
PLoS Medicine, Vol 3, Iss 5, p e138 (2006)
BACKGROUND: Candidate human papillomavirus (HPV) vaccines have demonstrated almost 90%-100% efficacy in preventing persistent, type-specific HPV infection over 18 mo in clinical trials. If these vaccines go on to demonstrate prevention of precancerou
Externí odkaz:
https://doaj.org/article/063836a0359e49ec9d8118a7b3dc4847